Financial reports
10-K
2023 FY
Annual report
16 Feb 24
10-Q
2023 Q3
Quarterly report
27 Oct 23
10-Q
2023 Q2
Quarterly report
28 Jul 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
29 Jul 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Departure of Directors or Certain Officers
29 Mar 24
8-K
Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
16 Feb 24
8-K
Balchem Corporation Announces Dividend
5 Dec 23
8-K
Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04
27 Oct 23
8-K
Departure of Directors or Certain Officers
5 Sep 23
8-K
Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06
28 Jul 23
8-K
Departure of Directors or Certain Officers
26 Jun 23
8-K
Results of Operations and Financial Condition
28 Apr 23
8-K
Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results
24 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
7 Dec 22
Registration and prospectus
S-8
Registration of securities for employees
28 Jun 23
S-8
Registration of securities for employees
4 Aug 17
S-8
Registration of securities for employees
25 Nov 08
25
Voluntary exchange delisting
21 Dec 06
8-A12B
Registration of securities on exchange
21 Dec 06
S-8
Registration of securities for employees
17 Aug 04
S-8
Registration of securities for employees
17 Aug 04
S-8
Registration of securities for employees
13 May 99
S-8 POS
Registration of securities for employees (post-effective amendment)
11 May 99
S-8
Registration of securities for employees
20 Jan 98
Proxies
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Jun 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
27 Apr 20
DEF 14A
Definitive proxy
27 Apr 20
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
4 Mar 19
UPLOAD
Letter from SEC
1 Nov 18
CORRESP
Correspondence with SEC
19 Oct 18
UPLOAD
Letter from SEC
5 Oct 18
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
28 Sep 18
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
15 Nov 17
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9 May 17
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
16 Mar 17
UPLOAD
Letter from SEC
29 Dec 11
CORRESP
Correspondence with SEC
28 Dec 11
Ownership
4
Michael Brent Tignor
12 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
4
Matthew David Wineinger
6 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
William A. Backus
27 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
144
Notice of proposed sale of securities
23 Feb 24
4
William A. Backus
23 Feb 24
4
Michael Robert Sestrick
23 Feb 24
4
Theodore L Harris
23 Feb 24